Briefing: Aerospace News & Updates

For an aerospace and defense markets analyst preparing recurring briefings for an informed retail/SMB investor who follows space and defense technology closely and cares about both engineering details and market impact.

Key Insights

• SpaceX's IPO is live, but the company you're buying isn't the one you modeled. SPCX priced at $135 and closed its first day at $161, raising $75B at a $1.77T valuation — the largest IPO in history by a wide margin. The critical underwriting issue isn't the valuation math; it's that SpaceX is allocating approximately 6x more capital to AI infrastructure than to space, has active hyperscaler compute contracts with Google and Anthropic, and is projecting AI compute satellite deployment by 2028. The 49% gross margin (targeting 70%) and 33% revenue growth look like a space company, but the capex mix increasingly looks like a hyperscaler — which means comparables, discount rates, and competitive moat analysis all need to shift. For investors entering SPCX: re-underwrite the position against AI infrastructure multiples, not aerospace multiples, and size the position knowing the 4.1% float will produce float-driven price swings of 15-20%+ on any material Starlink or Starship headline in the first 90 days.
• Your SpaceX IPO Primer and My GamePlan!
• SpaceX Finally Reveals The GIANT Starship Plan!

• Rocket Lab Weekly

• Starship V3 is converging on a monthly launch cadence, but the single gating item is Raptor 3 engine reliability. Booster 20 and Ship 40 are both receiving Raptor 3 engines simultaneously in Mega Bay 1 and 2, targeting a Flight 13 attempt within 4-6 weeks. SpaceX President Gwynne Shotwell has committed to monthly cadence following Flight 13, with orbital cargo delivery targeted for H2 2026. The infrastructure build-out supporting this — a second Mechazilla tower now stacking at SLC-37, the Gigabay completing structural steel across 24 production bays, and a 16-inch natural gas pipeline replacing unsustainable truck-based methane delivery — is real and investable, but these are 12-24 month plays. Flight 13's Raptor 3 performance is the near-term binary: a clean flight clears the single largest technical overhang on SpaceX's entire operational scaling thesis, while another engine anomaly (Flight 12 saw failures on both booster and upper stage) resets the cadence clock. For SPCX holders: Flight 13 outcome is the first material fundamental event post-IPO — plan your add/trim decision around that data point rather than day-one price action.

• Is the Artemis III HLS Starship Already Testing at Starbase?
• SpaceX Finally Reveals The GIANT Starship Plan!

• Your SpaceX IPO Primer and My GamePlan!

• Rocket Lab is executing a defense market penetration in compressed time. NASDAQ-100 inclusion effective June 22 arrives simultaneously with Rocket Lab being selected to supply satellite buses for Viasat's portion of the $438M PTSG Swarm One contract — a $4B IDIQ program for DoD protected satcom. The index inclusion creates structural passive buying support precisely as the company is demonstrating it can win multi-hundred-million-dollar defense hardware programs as a prime-level subcontractor. The internal target of six boosters/tails in simultaneous production (up from previous figures) is a manufacturing capacity signal, not a boast — it indicates demand visibility sufficient to justify the floor space commitment. Building on prior execution credibility from the SDA Tranche 3 SRR milestone and the $90M GEO Space Force contract, this trajectory describes a company compressing a decade of defense market penetration into roughly 18 months. For existing RKLB holders: the bus production cadence and RF/beam-steerable antenna M&A evaluation are the leading indicators to monitor in Q3 earnings — if manufacturing scales as signaled, the discount applied to backlog valuation compresses.

• Rocket Lab to Join NASDAQ-100 📈 | RLW | Episode 139 🚀

• Rocket Lab Weekly

• The Artemis 3 lunar landing has effectively slipped to 2028, and Blue Origin's May 28 New Glenn explosion compounds the HLS timeline pressure. NASA has restructured Artemis 3 from a lunar landing to a crewed LEO-only test mission, using a V3 Starship as an "HLS Pathfinder" to demonstrate Orion docking — the lunar landing now targets Artemis 4 around 2028. Separately, Blue Origin suffered a significant explosion anomaly on its New Glenn infrastructure on May 28, while its Mark 1 Blue Moon lander test unit targets orbital flight later this year. These two developments together — primary HLS contractor Blue Origin taking a hardware setback and NASA pulling the landing off Artemis 3 entirely — compress any investment thesis predicated on near-term lunar surface economy revenue. For investors holding LUNR: the LTV contract miss (previously flagged), the Artemis 3 restructuring, and Blue Origin's Blue Moon schedule pressure collectively argue for reassessing near-term revenue assumptions; the lunar landing gateway doesn't open before 2028 under any optimistic scenario.

• Is the Artemis III HLS Starship Already Testing at Starbase?
• SpaceX Finally Reveals The GIANT Starship Plan!

Emerging Patterns

1. SpaceX's capital allocation is bifurcating between near-term launch infrastructure and a longer-duration AI compute bet — and the market hasn't fully priced the identity ambiguity. The Gigabay, SLC-37 tower, and natural gas pipeline investments are credible evidence of sustained space commitment. But the 6x AI capex vs. space capex ratio from disclosed prospectus data, the 2028 AI compute satellite deployment target, and the hyperscaler contract revenue base suggest SpaceX's terminal value is increasingly underwritten by a different business than its brand implies. Multiple sources in this cycle agree on the factual AI pivot; what they disagree on is whether this is a risk, a feature, or noise — which means the market hasn't resolved it either.
2. Your SpaceX IPO Primer and My GamePlan!
3. SpaceX Finally Reveals The GIANT Starship Plan!

4. Rocket Lab Weekly

5. Rocket Lab is undergoing simultaneous institutional legitimization across market structure, defense contracting, and manufacturing capacity — a rare triple catalyst compression. NASDAQ-100 passive inflows, a sub-prime PTSG contract on a $4B IDIQ program, and a stated six-simultaneous-booster production target are not independent events — they are mutually reinforcing signals that the company has crossed a threshold from speculative small-cap to credible defense-grade integrator. Prior briefings established the SDA SRR milestone and GEO contract as foundational; this cycle's PTSG award and NASDAQ-100 inclusion extend the pattern into a durable trend rather than episodic wins.

6. Rocket Lab to Join NASDAQ-100 📈 | RLW | Episode 139 🚀
7. Rocket Lab Weekly

Dissenting Views

• On Starship's H2 2026 orbital cargo delivery timeline: the company says commitment, the analyst says "Elon time" — and this distinction matters for position sizing. SpaceX Finally Reveals The GIANT Starship Plan! presents Shotwell's orbital delivery guidance as high-certainty operational commitment with no qualification. Your SpaceX IPO Primer and My GamePlan! explicitly invokes "Elon time" as a structural reliability discount on any stated timeline, treating H2 2026 as aspirational rather than executable. This is a difference in confidence level, not a factual disagreement — both cite identical guidance. The practical implication is that investors who anchor near-term revenue models on Starship cargo delivery in 2026 are building on a foundation that SpaceX's own historical delivery pattern suggests is unreliable. Treat the H2 2026 orbital delivery target as a best-case scenario, not a base case, when modeling Starlink V3 constellation deployment and any downstream payload customer revenue timing.
• SpaceX Finally Reveals The GIANT Starship Plan!
• Your SpaceX IPO Primer and My GamePlan!

Read & Act

What to Read

• Your SpaceX IPO Primer and My GamePlan! — The most complete single treatment of the SPCX IPO in this cycle, combining specific mechanics (4.1% float, 49% gross margin, 70% target, retail allocation dynamics) with an explicit framework for re-underwriting SpaceX as an AI company. The valuation model implications of a hyperscaler identity vs. a launch monopoly identity cannot be summarized — you need the full reasoning chain to stress-test your own thesis.

• Is the Artemis III HLS Starship Already Testing at Starbase? — Uniquely integrates three concurrent risk signals — Artemis 3 restructuring to LEO-only, Blue Origin's New Glenn explosion, and the natural gas pipeline infrastructure — into a coherent near-term HLS timeline picture. The "de-risking vs. slippage" distinction is analytically important for any lunar economy exposure, and the full context is required to evaluate which frame is more accurate.

• SpaceX Finally Reveals The GIANT Starship Plan! — Best single-source reference document for the full inventory of concurrent SpaceX hardware, infrastructure, and financial developments across five capability tracks simultaneously. Less analytically critical than the IPO primer, but the breadth — Gigabay, SLC-37, Shotwell cadence commitment, LTV awards, IPO figures — makes it the right document to read when mapping scale.

What to Do

1. Re-underwrite your SpaceX position against AI infrastructure comparables before Flight 13. Pull the disclosed S-1 capex breakdown (6x AI vs. space ratio) and run a scenario model with two sets of comparables: one using aerospace/launch multiples, one using hyperscaler infrastructure multiples. The delta between these two valuations tells you how much of your SPCX thesis depends on which identity narrative wins in the market. Do this before Flight 13 results arrive — that event will move the stock on space narrative, but your sizing decision should be grounded in the AI identity question, not launch outcome noise from a 4.1% float.

2. Set a concrete Q3 earnings checklist for Rocket Lab tied to the six-booster production target and the RF antenna M&A signal. The PTSG award and NASDAQ-100 inclusion are now in the price; the next re-rating catalyst requires manufacturing execution. Before Q3 earnings, identify the specific metrics that confirm or deny the six-simultaneous-production rhythm — units in process, bus delivery schedule, any M&A announcement in the RF signal chain. If those metrics aren't disclosed, ask the question directly on the earnings call or flag it as a gap in your conviction level.

3. Reduce or exit any near-term lunar economy revenue model that assumes surface access before 2028. The Artemis 3 restructuring to LEO-only, Blue Origin's New Glenn anomaly, and the unresolved Starship cryogenic boil-off problem (flagged in prior briefings) together make a pre-2028 lunar landing scenario low-probability under any realistic program execution path. If LUNR is in your portfolio, the LTV miss combined with this structural Artemis delay removes the two near-term revenue catalysts that justified the position — the thesis needs to be rebuilt on a 2028+ timeline or exited.